Presentation: Enabling scalable cell engineering using the MaxCyte ExPERT electroporation platform
This content was presented at ABRF – Association of Biomolecular Resource Facilities March, 2022.
- Twenty years of experience in primary cell transfection, protein production, and genome engineering
- Continued expansion of cell therapy partnerships with leading industry innovators and multiple programs currently in clinical trials
- Trusted by the top academic, translational and commercial groups for their R&D, PD and MFG work